Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1
5-Year Impact Factor – 2.2
Scopus CiteScore – 3.4 (CiteScore Tracker 3.4)
Index Copernicus  – 161.11; MEiN – 140 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2020, vol. 29, nr 3, March, p. 307–312

doi: 10.17219/acem/116068

Publication type: original article

Language: English

License: Creative Commons Attribution 3.0 Unported (CC BY 3.0)

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

Antibiotic-resistant bacterial colonization increases the number of hospitalizations in patients after solid organ transplantation or with non-communicable diseases

Bożena Czarkowska-Pączek1,2,A,C,D,E,F, Elżbieta Wawiórko1,B,E,F, Grażyna Młynarczyk2,B,E,F, Leszek Paczek3,A,C,E,F

1 Department of Clinical Nursing, Medical University of Warsaw, Poland

2 Chair and Department of Medical Microbiology, Medical University of Warsaw, Poland

3 Department of Immunology, Transplantology and Internal Diseases, Medical University of Warsaw, Poland


Background. Healthcare-associated infections could affect the rate of morbidity, mortality and post-discharge hospitalization among patients. They are also dangerous to healthcare professionals and generate significant cost to the healthcare system.
Objectives. The aim of this study was to evaluate the occurrence rate of colonization with various antibiotic-resistant (AR) bacteria among patients admitted to the Department of Immunology, Transplantology and Internal Diseases.
Material and Methods. The study used retrospective analysis of patients (n = 280) with no clinical signs of infection admitted into the department between November 2015 and May 2017. The observational period lasted until January 2019. Collected data included sex, age at admission, location directly prior to current hospitalization, and medical history. Nasal and rectal swabs were collected, and stool and urine samples were obtained on the day of admission. Specimens were cultured according to standard microbiological procedures. In all cases, the appropriate bioMerieux (Marcy-l’Étoile, France) media were used. Isolates were identified using mass spectrometer (Vitek MS; bioMerieux).
Results. One-hundred ninety-one (68.2%) of patients were colonized with AR bacteria. The incidence of colonization was not influenced by age or sex. The risk of colonization was associated with admission from another hospital and history of kidney transplantation (p = 0.0136 and p < 0.001, respectively). The number of hospitalizations during the whole observational period was higher in the group of colonized patients compared to non-colonized (2.76 ±2.4 vs 2.07 ±1.68, p = 0.0099). The number of hospitalizations correlated positively with the number of positive cultures obtained from the same patients (rho = 0.18, p = 0.0274).
Conclusion. The rate of colonization at admission to the ward could be high, depending on previous hospitalization and medical history. Colonization significantly increased post-discharge hospitalization rate.

Key words

hospitalization rate, healthcare-associated infections, bacterial colonization

References (24)

  1. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160–166.
  2. Friedrich AW. Control of hospital acquired infections and antimicrobial resistance in Europe: The way to go. Wien Med Wochenschr. 2019;169(Suppl 1):25–30. doi:10.1007/s10354-018-0676-5
  3. Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66. doi:10.1016/S1473-3099(18)30605-4
  4. Kampmeier S, Knaack D, Kossow A, et al. A. Weekly screening supports terminating nosocomial transmission of vancomycin-resistant Enterococci on an oncologic ward: A retrospective analysis. Anti­microb Resist Infect Control. 2017;6:48. doi:10.1186/s13756-017-0206-z
  5. Scott II RD. The direct medical costs of health-care associated infections in U.S. hospitals and the benefits from prevention. Accessed February 4, 2019.
  6. Ludden C, Cormican M, Vellinga A, Johnson JR, Austin B, Morris D. Colonisation with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistance enterococci, and methi­cillin-resistant Staphylococcus aureus in a long-term care facilities. BMC Infect Dis. 2015;15:168.
  7. Thuy DB, Campbell J, Nhat LTH, et al. Hospital-acquired colonization and infections in Vietnamese intensive care unit. PLoS One. 2018;13(9):e0203600. doi:10.1371/journal.pone.0203600
  8. Derde LPG, Cooper BS, Goossens H, et al. Interventions to reduce colonisation and transmission of antimicrobial-resistant bacteria in intensive care units: An interrupted time series study and cluster randomised trial. Lancet Infect Dis. 2014;14(1):31–39. doi:10.1016/S1473-3099(13)70295-0
  9. Faron ML, Ledeboer NA, Buchan BW. Resistance mechanisms, epidemiology, and approaches to screening for vancomycin-resistant Enterococcus in the health care setting. J Clin Microbiol. 2016;54(10):2436–2447. doi:10.1128/JCM.00211-16
  10. Huang SS, Singh R, McKinnell JA, et al. Decolonization to reduce postdischarge infection risk among MRSA carriers. N Engl J Med. 2019;380(7):638–650. doi:10.1056/NEJMoa1716771
  11. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters, v. 9.0, 2019.
  12. Miriagou V, Tzelepi E, Kotsakis SD, Daikos GL, Bou Casals J, Tzouve­lekis LS. Combined disc methods for the detection of KPC- and/or VIM-positive Klebsiella pneumoniae: Improving reliability for the double carbapenemase producers. Clin Microbiol Infect. 2013;19(9):E412–415.
  13. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503–1507.
  14. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: A clinical update. Clin Microbiol Rev. 2005;18(4):657–686.
  15. The European Committee on Antimicrobial Susceptibility Testing. The EUCAST guideline on detection of resistance mechanisms v. 1.0 (2013-12-11).
  16. Sekowska A, Gospodarek E, Kusza K. The prevalence of infections and colonisations with Klebsiella pneumoniae strains isolated in ICU patients. Anaesthesiol Intensive Ther. 2014;46(4):295–298.
  17. Talaga K, Odrowąż-Konduracka D, Paradowska B, et al. Typing of Enterococcus spp. strains in 4 hospitals in the Małopolska region in Poland. Adv Clin Exp Med. 2018;27(1):111–117. doi:10.17219/acem/68265
  18. Balletto E, Mikulska M. Bacterial infections in hematopoietic stem cell transplant recipients. Mediterr J Hematol Infect Dis. 2015;7(1):e2015045. doi:10.4084/MJHID.2015.045
  19. Chmielarczyk A, Pobiega M, Ziółkowski G, et al. Severe infections caused by multidrug-resistant non-fermentative bacilli in southern Poland. Adv Clin Exp Med. 2018;27(3):401–407. doi:10.17219/acem/68545
  20. Rodriguez C, Taminiau B, Korsak N, et al. Longitudinal survey of Clostridium difficile presence and gut microbiota composition in a Belgian nursing home. BMC Microbiol. 2016;16(1):229.
  21. Furuya-Kanamori L, Marquess J, Yakob L, et al. Asymptomatic Clostridium difficile colonization: Epidemiology and clinical implications. BMC Infect Dis. 2015;15:516. doi:10.1186/s12879-015-1258-4
  22. Loo VG, Bourgault AM, Poirier L, et al. Host and pathogen factors for Clostridium difficile infection and colonization. N Engl J Med. 2011;365(18):1693–1703. doi:10.1056/NEJMoa1012413
  23. Curry SR, Muto CA, Schlackman JL, et al. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis. 2013;57(8):1094–1102. doi:10.1093/cid/cit475
  24. Yakob L, Riley TV, Paterson DL, Clements AC. Clostridium difficile exposure as an insidious source of infection in healthcare settings: An epidemiological model. BMC Infect Dis. 2013;13:376. doi:10.1186/1471-2334-13-376